Orange Book product · Generic (ANDA)
CEPHRADINE
CEPHRADINE
At a glance
Jan 09, 1987
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 09, 1987
40 yr ago
Today
Pharmaceutical detail
Active ingredient
CEPHRADINE
Strength
125MG/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 062693
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEPHRADINE
- —VELOSEF '250'Brand (NDA)
NDA 050548 · ERSANA
- —VELOSEFBrand (NDA)
NDA 050530 · BRISTOL MYERS SQUIBB
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062858 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062859 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062850 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062851 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062813 · VITARINE
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062762 · IVAX SUB TEVA PHARMS
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062683 · TEVA
- —ANSPORGeneric (ANDA)
ANDA 061859 · GLAXOSMITHKLINE
- —VELOSEFGeneric (ANDA)
ANDA 061764 · APOTHECON
- —ANSPORGeneric (ANDA)
ANDA 061866 · GLAXOSMITHKLINE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
